Endotoxin and hypoxia-induced intestinal necrosis in rats: The role of platelet activating factor

Pediatric Research

Volumn 31, Issue 5, 1992, Pages 428-434

  Caplan, Michael S ^a,b   Kelly, Anne ^a,b   Hsueh, Wei ^a,b  

^a Department of Radiation Medicine   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; HYDROLASE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; HEMOCONCENTRATION; HYPOTENSION; HYPOXIA; INTESTINE NECROSIS; MALE; MESENTERY BLOOD FLOW; METABOLIC ACIDOSIS; NECROTIZING ENTEROCOLITIS; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RAT; RISK FACTOR;

ANIMAL; ANOXIA; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; INTESTINES; LIPOPOLYSACCHARIDES; MALE; PLATELET ACTIVATING FACTOR; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026607430     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/00006450-199205000-00002     Document Type: Article

References (34)

1. Ryder RW, Shelton JD, Guinan ME 1980 Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 112:112-123
2. Kliegman RM, Fanaroff AA 1984 Necrotizing enterocolitis. N Engl J Med 310:1093-1103
3. Touloukian RJ, Posch JN, Spencer R 1972 The pathogenesis of ischemic gastroenterocolitis of the neonate: selective gut mucosal ischemia in asphyxiated neonatal piglets. J Pediatr Surg 7:194-205
4. Gonzalez-Crussi F, Hsueh W 1983 Experimental model of ischemic bowel necrosis: the role of platelet-activating factor and endotoxin. Am J Pathol 112:127-135
5. Hsueh W, Gonzalez-Crussi F, Arroyave JL 1987 Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1:403-405
6. Wallace JL, Steel G, Whittle BJR, Lagente V, Vargaftig B 1987 Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat: effects of three platelet-activating factor antagonists. Gastroenterology 93:765-773
7. Caplan MS, Sun XM, Hsueh W, Hageman JR 1990 The role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 116:960-964
8. Farr RS, Wardlow ML, Cox CP, Meng KE, Greene DE 1983 Human serum acid-labile factor is an acylhydrolase that inactivates platelet activating factor. Fed Proc 42:3120-3122
9. Caplan M, Hsueh W, Kelly A, Donovan M 1990 Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 39:705-714
10. Traccy KJ, Vlassara H, Cerami A 1989 Cachectin/tumour necrosis factor. Lancet 1:1122-1126
11. Sun XM, Hsueh W 1988 Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet activating factor. J Clin Invest 81:1328-1331
12. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey III TJ, Zentella A, Albert JD, Shires GT, Cerami A 1986 Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474
13. Caplan MS, Sun XM, Hsueh W 1990 Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether). Gastroenterology 99:979-986
14. Barlow B, Santulli TV, Heird WC, Pitt J, Blanc WA, Schullinger JN 1974 An experimental study of acute neonatal enterocolitis: the importance of breast milk. J Pediatr Surg 9:587-594
15. Casals-Stenzel J, Muacevic G, Weber KH 1987 Pharmacological actions of WEB 2086, a new specific antagonist to platelet-activating factor. J Pharmacol Exp Ther 241:974-981
16. Handley DA, Van Valen RG, Tomesch JC, Melden MK, Jaffe JM, Ballard FH, Saunders RN 1987 Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in rat and dog. Immuno-pharmacology 13:125-132
17. Hsueh W, Gonzalez-Crussi F, Arroyave JL 1986 Platelet-activating factorinduced ischemic bowel necrosis: an investigation of secondary mediators in its pathogenesis. Am J Pathol 122:231-239
18. Hsueh W, Gonzalez-Crussi F, Arroyave F, Anderson JL, Lee ML, Houlihan WJ 1986 Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists. Eur J Pharmacol 123:79-83
19. Folch J, Lees M, Sloane Stanley GH 1957 A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
20. Blank ML, Snyder F 1983 Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids. J Chromatogr 273:415-420
21. Hansbrough F, Priebe Jr CJ, Falterman KW, Bornside GH, Welsh RA 1983 Pathogenesis of early necrotizing enterocolitis in the hypoxic neonatal dog. Am J Surg 145:169-175
22. Santulli TV, Schullinger JN, Heird WC, Gongaware RD, Wigger J, Barlow B, Blanc WA, Berdon WE 1975 Acute necrotizing enterocolitis in infancy: a review of 64 cases. Pediatrics 55:376-387
23. Hanahan DJ 1986 Platelet activating factor: a biologically active phosphoglyc-eride. Ann Rev Biochem 35:483-509
24. Chang SW, Feddersen CO, Henson PM, Voelkel NF 1987 Platelet activating factor mediates hemodynamic changes and lung injury in cndotoxin-treated rats. J Clin Invest 79:1498-1509
25. Hsueh W, Gonzalez-Crussi F, Arroyave JL 1988 Sequential release of leukotrienes and norepinephrine in rat bowel after platelet activating factor: a mechanistic study of platelet activating factor-induced bowel necrosis. Gastroenterology 94:1412-1418
26. Llausas-Magana E, Hsueh W, Arroyave CM, Arroyave JL, Torre-Amione G, Gonzalez-Crussi F 1988 Cobra venom factor, an activator of the complement system, enhances the bowel necrosis induced by platelet-activating factor. Immunopharmacology 15:31-38
27. Cueva JP, Hsueh W 1988 Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. Gut 29:1207-1212
28. Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D 1990 Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J Clin Invest 85:1090-1098
29. Mozes T, Braquet P, Filep J 1989 Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Phvsiol 257:R872-R877
30. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O’Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW 1988 Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486
31. Fong Y, Marano MA, Moldawer LL, Wei H, Calvano SE, Kenney JS, Allison AC, Cerami A, Shires GT, Lowry SF 1990 The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85:1896-1904
32. Bonavida B, Mencia-Huerta J-M, Braquet P 1989 Effect of platelet activating factor on monocyte activation and production of tumor necrosis factor. Int Arch Allergy AppI Immunol 88:157-160
33. Camussi G, Bussolino F, Salvidio G, Baglioni C 1987 Tumor necrosis factor/ cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 166:1390-1404
34. Kriegler M, Perez C, DeFay K, Albert I, Lu SD 1988 A novel form of TNF/ cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53